|
|
|
| 目录号 |
产品名称 |
品牌 |
CAS号 |
包装 |
市场价 |
优惠价 |
货期 |
| 15/148 |
Influenza Virus Infectious NIB-92
Influenza Virus Infectious NIB-92 |
NIBSC/WHO |
|
|
| 15/150 |
Influenza anti-B/Phuket/3073/2013 HA serum
Influenza anti-B/Phuket/3073/2013 HA serum |
NIBSC/WHO |
|
|
| 15/154 |
Influenza Virus Infectious NIB-93
Influenza Virus Infectious NIB-93 |
NIBSC/WHO |
|
|
| 15/158 |
Influenza Virus Infectious NYMC X-263
Influenza Virus Infectious NYMC X-263 |
NIBSC/WHO |
|
|
| 15/160 |
Influenza Virus Infectious NIBRG-306
Influenza Virus Infectious NIBRG-306 |
NIBSC/WHO |
|
|
| 15/174 |
Lupus (oligo-specific) anti-dsDNA antibodies WHO Reference Reagent
Lupus (oligo-specific) anti-dsDNA antibodies WHO Reference Reagent |
NIBSC/WHO |
|
|
| 15/180 |
Blood Coagulation Factor XI, 2016 Plasma Human (2nd International Standard). Blood Coagulation Factor XII, 2017 Plasma, Human (1st International Standard)
Blood Coagulation Factor XI, 2016 Plasma Human (2nd International Standard). Blood Coagulation Factor XII, 2017 Plasma, Human (1st International Standard) |
NIBSC/WHO |
|
|
| 15/182 |
7th British Working Standard for Blood Coagulation Factors II, IX, X Concentrate
7th British Working Standard for Blood Coagulation Factors II, IX, X Concentrate |
NIBSC/WHO |
|
|
|
|
